Understanding Mirena’s two FDA-approved durations should be part of shared contraceptive decision-making. The best option depends on effectiveness goals, bleeding preferences, medical eligibility, medication interactions, desired duration, insertion comfort, and how quickly pregnancy may be desired later.

Most adnexal masses are benign, but age, symptoms, menopause status, ultrasound features, and change over time determine observation, surgery, or referral.

How estrogen-free pills differ from combined oral contraceptives is best understood through individualized contraceptive counseling. Effectiveness, bleeding goals, medical history, medication interactions, convenience, reversibility, and comfort with side effects all matter. No birth control method protects against sexually transmitted infections, so condoms may still be recommended.

A complete infertility evaluation looks at ovulation, ovarian reserve, uterine anatomy, fallopian tubes, semen, timing, age, and prior pregnancy history.

Mood, anxiety, sleep, trauma, reproductive transitions, medications, and physical symptoms often overlap. Learn what an OB-GYN can screen, treat, and refer.

Bleeding changes are common in perimenopause, but pregnancy, fibroids, polyps, thyroid disease, hyperplasia, and cancer still require consideration.